ACAD
Acadia Pharmaceuticals Inc. · Healthcare
EVP, COO, Head of Commercial Brendan Teehan sold $59K of Acadia Pharmaceuticals Inc.
Sold$58,900
$16.94Price
3,477Shares
−8%Stake
What ACAD did after the filing
- The stock from Fri, May 3 close, $17.05
- −13.0%
- S&P 500, same days
- +7.0%
Measured over 30 trading days, to the Jun 17 close.
Traded Thu, May 2. Filed Fri, May 3, 2:00 PM ET, during the session. Returns use the May 3 close and the Jun 17 close. Not investment advice.